Megha Rao, MD
Internal Medicine · New Brunswick, NJNPI 1629368097
Payments from drug & device makers
Across 77 payments — averaging $32.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$828
- Novo Nordisk$242
- Boston Scientific$149
- Sanofi$145
- Abiomed$120
- LEO Pharma Inc.$120
- plus $929 from 19 others
What the payments were for
- Food & beverage$2,535100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 19 | $828 |
| Novo Nordisk | 16 | $242 |
| Boston Scientific | 1 | $149 |
| Sanofi | 1 | $145 |
| Abiomed | 1 | $120 |
| LEO Pharma Inc. | 1 | $120 |
| Medtronic | 2 | $119 |
| Edwards Lifesciences | 1 | $111 |
| Intuity Medical Inc | 2 | $88 |
| Lilly USA, LLC | 6 | $87 |
| Kestra Medical Technology Services, Inc. | 1 | $70 |
| Exact Sciences | 3 | $58 |
| Cvrx, Inc. | 1 | $53 |
| Pfizer | 4 | $51 |
| Sanofi-aventis U.S. LLC | 3 | $49 |
| Insulet Corporation | 2 | $47 |
| Scilex Pharmaceuticals Inc. | 3 | $42 |
| Amryt Pharma Holdings Ltd | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Boehringer Ingelheim | 1 | $17 |
| Corcept Therapeutics | 1 | $16 |
| Mannkind Corporation | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,535 in reported general payments places this provider in the 80th percentile of 4,032 internal medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 162 | $1,368 |
| Amlodipine Besylate | 117 | $850 |
| Rosuvastatin Calcium | 60 | $824 |
| Levothyroxine Sodium | 51 | $661 |
| Metformin Hcl ErMetformin Hcl | 45 | $591 |
| Pravastatin Sodium | 39 | $551 |
| Lisinopril | 54 | $537 |
| Losartan Potassium | 54 | $442 |
| Metoprolol Succinate | 30 | $370 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $354 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 16 | $300 |
| Metformin Hcl | 36 | $271 |
| Chlorthalidone | 13 | $264 |
| Atenolol | 17 | $263 |
| Metoprolol Tartrate | 20 | $251 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in New Brunswick
- Jeffrey CarsonNew Brunswick$13.8M
- Soko Setoguchi IwataNew Brunswick$537K
- Stephen MarcellaNew Brunswick$331K
- Joseph FerroNew Brunswick$263K
- Darren SerilNew Brunswick$137K
- Steven PeskinNew Brunswick$99K
- Sanjiv SharmaToms River$33.9M
- Samer HaddadHamilton$6.8M
- Magdy ShenoudaWall$3.7M
- Samar HameedLivingston$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.